Taco Bell Indonesia Officially Opens Its First Restaurant in Jakarta
Taco Bell Indonesia Officially Opens Its First Restaurant in Jakarta JAKARTA, Dec 19, 2020 – (ACN Newswire) – Taco Bell
Read more
Author: vanessa
Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications Support
VANCOUVER, BC,Dec. 15, 2020/CNW/ –Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona“) is pleased to announce that it has
Read more
Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras
LAVAL, QC, and CAMBRIDGE, England, Dec. 15, 2020/CNW Telbec/ – Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”),
Read more
BIOREM Announces Research Project with City of New York to Control Release of Bioaerosols from Waste Water Treatment Facilities
GUELPH, ON, Dec. 14, 2020/CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced a research project in
Read more
Mountain Valley MD Confirms 800% Increase in Ivermectin Absorption with Solubilization Technology in Pre-Clinical Trial
VANCOUVER, BC,Dec. 10, 2020/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased to announce
Read more
Abcam reveals new cell engineering facility in Bay Area
CAMBRIDGE, England,Dec. 8, 2020/CNW/ — Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening
Read more
Sierra Oncology Presents Long-term Overall Survival and Sustained Efficacy Outcomes Data for Momelotinib at ASH Annual Meeting
–Momelotinib demonstrates robust overall survival in both JAKi-naïve and patients previously treated with ruxolitinib– VANCOUVER, BC,Dec. 5, 2020/CNW/ – Sierra Oncology,
Read more
Dragonfly Therapeutics Announces Merck Opt-In of TriNKET(TM) Immunotherapy Candidate for Patients with Solid Tumors
Canada NewsWire WALTHAM, Mass., Dec. 1, 2020 Merck executes option to license its first immunotherapy candidate from the companies’ 2018
Read more
Nova Mentis Life Science Completes Acquisition of Pilz Bioscience
Canada NewsWire VANCOUVER, BC, Nov. 30, 2020 VANCOUVER, BC,Nov. 30, 2020/CNW/ –Nova Mentis Life Science Corp.(CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF)(“NOVA”
Read more
ImmunoPrecise Antibodies Ranked Number 240 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500(TM)
Canada NewsWire VICTORIA, BC, Nov. 25, 2020 VICTORIA, BC,Nov. 25, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV:
Read more